Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-05-18 @ 5:45 AM
Study NCT ID:
NCT00310804
Status:
COMPLETED
Last Update Posted:
2019-08-15
First Post:
2006-04-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)
Sponsor:
Novartis Vaccines
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
V58P9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None